We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RSSS:NASDAQResearch Solutions, Inc Analysis

Data as of 2026-04-29 - not real-time

$2.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Research Solutions, Inc. is trading just above its short‑term moving average with a neutral price trend, while the MACD line has just nudged above its signal line, suggesting a modest bullish bias. The RSI sits near the midpoint, indicating neither overbought nor oversold conditions, and volume has remained stable, supporting the current price action. Volatility remains elevated, but the stock’s beta is below one, implying lower systematic risk than the broader market. Fundamentals show a solid cash position, no debt, and healthy operating margins, with a return on equity well above industry averages. The discounted cash flow model values the company at roughly double the current market price, and the price‑to‑earnings multiple is considerably lower than the sector average, pointing to a sizable valuation gap. These factors combine to create a compelling upside narrative despite modest revenue growth.
Given the attractive valuation, strong cash generation, and a risk profile marked by low beta and stable liquidity, the stock appears positioned for a rebound. The lack of dividend does not impact the investment case, as the primary driver is capital appreciation. However, investors should remain mindful of sector competition and regulatory considerations tied to data services. Overall, the technical and fundamental signals align toward a favorable medium‑ to long‑term outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover
  • Stable trading volume
  • Price near short‑term moving average

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant upside relative to DCF fair value
  • Low beta reducing market volatility exposure
  • Strong cash generation and zero debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Growing demand for AI‑enhanced research tools
  • High return on equity and solid profit margins
  • Durable competitive moat from proprietary data platform

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin7.87%
P/E Ratio20.4
ROE27.32%
ROA4.97%
P/B Ratio4.5
Op. Cash Flow$7.6M
Free Cash Flow$9.3M
Industry P/E37.5

Technical Analysis

TrendNeutral
RSI50.5
Support$2.20
Resistance$2.64
MA 20$2.45
MA 50$2.39
MA 200$2.87
MACDBullish
VolumeStable
Fear & Greed Index89.59

Valuation

Fair Value$4.17
Target Price$5.00
Upside/Downside104.08%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.67
Volatility43.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.